Oncotarget has made itself one of the most respected names in publishing out there. Oncologists like the work of Oncotarget and they themselves would like to do what they can to help it become a better science journal. Right now, researchers are publishing some of the most important oncology articles through the journal in order to have their voice heard. Although they are many challenges in the modern fight against cancer, it seems that Oncotarget is doing its part to make sure the cutting edge continues to expand. The results are very easy to see for just about anybody willing. Follow Oncotarget on Twitter.
The most recent expansion of Oncotarget gives it the power to publish twice a week. That means researchers are able to find the latest work they need on a much more frequent basis. The ability to improve on our current understanding of cancer is how we have gotten as far as we have today. There are other cancer research journals out there but none appear to have reached the same status as Oncotarget. Few have managed to gain so many supporters and few have managed to attract the same level of dedication. There’s something about Oncotarget that separates it from other research journals.
There are a number of categories for articles on Oncotarget, but they all handle some aspect of cancer. Some articles deal with blood cancers and others with cancers of specific organs. There are articles discussing the methods of treatment and how to create a more efficient means of fighting cancer. This research allows this journal to serve as a platform for innovation. Important changes to the way we think about cancer are going on right now thanks to Oncotarget.
The future is bright for Oncotarget, but there needs to be even greater investments in the research journal. More oncologists need to make Oncotarget their preferred research journal. When that happens the world is going to see some serious breakthroughs in cancer research. The desire to find the most impressive discoveries yet is being fulfilled by the tireless work of this scientific research journal and its hard working publishers. Visit Oncotarget’s profile page at facebook.com